Your Cart
Your cart is empty

Looks like you haven't added any test / checkup to your cart

Add Test / Checkup
acetone-serum

TEL/AML -Qualitative PCR Diagnostic Test

The TEL/AML - Qualitative PCR Diagnostic Test is a laboratory procedure used to detect the presence of a specific type of genetic rearrangement. This involves the fusion of two genes, the TEL (also known as ETV6) and the AML1 (also known as RUNX1). This particular genetic fusion is often associated with certain types of leukemia, including acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML).


  • Test NameTEL/AML -Qualitative PCR Diagnostic Test
  • Sample TypeBlood
  • Preparations RequiredThere are no specific preparations required for this test. Continue your regular diet and medication schedule unless otherwise instructed by your physician.
  • Report Time5 Days

The presence of the TEL/AML fusion gene doesn't necessarily mean a person has leukemia, but it is a strong risk factor and is often used in conjunction with other tests to confirm a diagnosis. The test involves analyzing a sample of your blood using polymerase chain reaction (PCR), a technique that amplifies small amounts of DNA to make it easier to study.

Home Sample Collection Process

1
Book your convenient slot
Book your convenient slot
2
Sample Collection by Phlebotomist
Sample Collection by Phlebotomist
3
Reporting of the sample at lab
Reporting of the sample at lab
4
Download Reports
Download Reports
Frequently Asked Questions

This test is important because it aids in diagnosing specific types of leukemia, and helps in determining the most effective treatment plan. It can also be used to monitor response to treatment and detect any possible recurrence of the disease.

No, fasting is not required for this test. You can continue your regular diet and medication schedule unless instructed otherwise by your healthcare provider.

Your doctor may recommend this test if you have symptoms of leukemia, such as fatigue, fever, weight loss, or frequent infections. It might also be ordered if you've already been diagnosed with leukemia and your doctor needs to determine the specific type or monitor your response to treatment.

This test detects the presence of the TEL/AML fusion gene in your blood, which is often associated with certain types of leukemia.

The frequency of testing depends on your health condition and the treatment plan recommended by your doctor. Your doctor might order this test at diagnosis, during treatment to monitor response, and after treatment to detect any potential recurrence.

In a healthy individual, the TEL/AML fusion gene is not typically present. However, detecting it does not necessarily mean a person has leukemia, as it can occasionally be found in healthy people.

No specific precautions are necessary. Continue your regular diet and medication schedule unless otherwise instructed by your doctor.

The presence of the TEL/AML fusion gene is typically associated with the development of certain types of leukemia. Factors such as age, exposure to certain chemicals, and a history of certain genetic disorders can increase the risk of developing leukemia.

If your test results are abnormal, you should consult a hematologist or an oncologist, doctors who specialize in blood disorders and cancer respectively.

The risks associated with this test are minimal and are similar to those of a regular blood draw, including mild discomfort or bruising at the injection site.

Certain medications might affect the results of this test. Always inform your doctor about any medications, supplements, or therapies you are currently undergoing.

Yes, this test can be used to monitor response to treatment and detect any potential recurrence of the disease.

Yes, while rare, the TEL/AML fusion gene can occasionally be found in healthy people. However, its presence is typically associated with the development of certain types of leukemia.

Your doctor might order other tests to confirm a diagnosis of leukemia, such as a complete blood count (CBC), bone marrow biopsy, or other genetic tests.

No, lifestyle changes won't affect the presence of this fusion gene as it is a genetic alteration. However, a healthy lifestyle can support overall health and well-being during treatment for leukemia.

Yes, children can also undergo this test. In fact, TEL/AML fusion gene is often associated with childhood acute lymphoblastic leukemia (ALL).

The test is highly accurate. PCR technology is known for its sensitivity and specificity in detecting genetic material, making it a reliable tool for diagnosing and monitoring conditions like leukemia.

The turnaround time for the test results is typically 3 to 7 days. However, it may vary depending on the laboratory.

Not necessarily. While the presence of the TEL/AML fusion gene is associated with certain types of leukemia, not everyone who has this fusion gene will develop the disease. It is, however, a significant risk factor and needs to be closely monitored.

Like any other blood tests, drawing blood can cause slight discomfort or fear, especially in children. Comfort your child, and explain to them why the test is needed in a language they can understand. You may also distract them during the blood draw with a toy or a game.

Understanding the TEL/AML -Qualitative PCR Diagnostic Test, its necessity, and its results is essential in diagnosing and managing leukemia. The knowledge provides insights and helps guide the path towards the most suitable treatment. Always remember to discuss the results with your healthcare provider to fully understand your medical condition. In case you have any queries or concerns, do not hesitate to reach out to your healthcare provider.

Schedule Test in Your Available Time
Locations Near You in Hyderabad
  • 4KM from Madhapur
  • 3KM from Banjara Hills
  • 1.9KM from Yusufguda
  • 3KM from Madhura Nagar
  • 5KM from Shaikpet